Abstract: We analyzed the consensus earnings revisions of HSI component stocks for August 2026, finding that the index's 2026E EPS rose 0.50% month-on-month to HK$2,164, even as the HSI index itself declined 1.2% to 25,585. Among the 83 constituents reviewed, 49 stocks saw upward EPS revisions versus 34 downward, with individual stock EPS changes attributing HK$10.0 to the index's EPS movement. The largest positive contributors to index EPS were CHINA LIFE (+HK$5.6), CK HUTCHISON (+HK$4.1), and PING AN (+HK$2.7), while the biggest drags were Kuaishou (-HK$7.1), XIAOMI (-HK$3.7), and BIDU (-HK$2.6). On a stock-level basis, the steepest EPS upgrades went to LI AUTO (+225%), BEONE MEDICINES (+36.2%), and SMIC (+31.4%), while XINYI SOLAR (-44.9%), Kuaishou (-34.3%), and Pop Mart (-17.7%) saw the sharpest cuts.
XINYI SOLAR, BIDU, CSPC PHARMA, Kuaishou, Pop Mart Intl, SHENZHOU INTERNATIONAL
A monthly review of consensus earnings revisions for HSI constituents. Each issue estimates how the index's forward EPS changed over the month, and tabulates the stocks with the largest impact on index EPS alongside their EPS and revenue revisions. All issues of Index Earnings Revision Monthly →
Interested in the full report? Get in touch with our team.